赛科希德收盘下跌1.77%，滚动市盈率21.30倍，总市值24.70亿元

Group 1 - The core viewpoint of the article highlights the financial performance and market position of Saikohide, a company specializing in diagnostic instruments and reagents for thrombosis and hemostasis [1] - As of April 16, Saikohide's closing price was 23.27 yuan, with a rolling price-to-earnings (PE) ratio of 21.30 times, and a total market capitalization of 2.47 billion yuan [1] - The average PE ratio for the medical device industry is 45.94 times, with a median of 29.64 times, placing Saikohide at the 48th position in the industry ranking [1] Group 2 - As of the third quarter of 2024, 37 institutions hold shares in Saikohide, all of which are funds, with a total holding of 4.7493 million shares valued at 115 million yuan [1] - The company reported a revenue of 227 million yuan for the third quarter of 2024, representing a year-on-year increase of 10.89%, while net profit was 83.6587 million yuan, showing a year-on-year decrease of 4.74% [1] - The sales gross margin for Saikohide stands at 62.13% [1]